Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4523

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-4523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Mm1 (Cyclobenzaprine HCl 30mg 70518 4523 00)

Mm1 (Cyclobenzaprine HCl 30mg 70518 4523 00)
This is a description of Cyclobenzaprine HCI Extended-Release 30 mg capsules. The capsules are repackaged by RemedyRepack Inc. in Indiana, PA. The usual dosage instructions can be found in the insert provided. The medication should be kept out of reach of children and stored at 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F) as per USP guidelines. The manufacturer is TW Pharmaceuticals USA located in Paramus, NJ.*
FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
FDA Label Image

Image (Image 2)

Image (Image 2)
FDA Label Image

Image (Image 3)

Image (Image 3)
FDA Label Image

Image (Image 4)

Image (Image 4)
FDA Label Image

Image (Image 5)

Image (Image 5)
FDA Label Image

Image (Image 6)

Image (Image 6)
FDA Label Image

Image (Image 7)

Image (Image 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.